An open label, comparative, multicentric study to assess the efficacy and safety of fixed dose combination tablets of Nebivolol & Indapamide (as sustained release) in comparison with Nebivolol tablets in patients suffering from hypertension.
Phase of Trial: Phase III
Latest Information Update: 01 Sep 2016
At a glance
- Drugs Indapamide/nebivolol (Primary) ; Nebivolol
- Indications Hypertension
- Focus Registrational; Therapeutic Use
- Sponsors Cadila Healthcare
- 10 Apr 2010 Status changed from active, no longer recruiting to completed as reported by Clinical Trials Registry - India record.
- 19 Mar 2010 Status changed from recruiting to active, no longer recruiting as reported by Clinical Trials Registry - India
- 08 Feb 2010 New trial record